vimarsana.com

Latest Breaking News On - Semaglutide treatment - Page 1 : vimarsana.com

Study Estimates More than 90 Million US Adults Could Benefit from Semaglutide 2 4 mg

Using data and eligibility criteria from the STEP 1 trial, a California-based team estimates 93 million US adults met criteria for semaglutide 2.4 mg and use could prevent 1.5 million incident cardiovascular events over a 10-year period.

Study: 93 million U S adults may benefit from semaglutide medication

Researchers from the University of California, Irvine have just published a study that projects 93 million U.S. adults that are overweight and obese may be suitable for the 2.4 mg dosage of semaglutide, a weight loss medication known under the brand name Wegovy.

Recent study finds that semaglutide medication may benefit 93 million U S adults

Recent study finds that semaglutide medication may benefit 93 million U S adults
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.